Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
Condition(s):Prostatic Hyperplasia; Prostate Hyperplasia; Prostatic HypertrophyLast Updated:August 27, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Prostatic Hyperplasia; Prostate Hyperplasia; Prostatic HypertrophyLast Updated:August 27, 2021Unknown status
Condition(s):Benign Prostatic HyperplasiaLast Updated:December 2, 2019Completed
Condition(s):Urinary Bladder, OveractiveLast Updated:January 7, 2016Completed
Condition(s):Prostatic HyperplasiaLast Updated:November 9, 2016Completed
Condition(s):Males With Benign Prostatic Hyperplasia SymptomsLast Updated:August 10, 2020Unknown status
Condition(s):Benign Prostatic Hyperplasia (BPH)Last Updated:February 28, 2024Recruiting
Condition(s):Benign Prostatic HyperplasiaLast Updated:February 11, 2022Not yet recruiting
Condition(s):Urinary Problems; Prostate CancerLast Updated:September 21, 2021Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:October 7, 2016Completed
Condition(s):Crohn’s Disease; Perianal FistulasLast Updated:March 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.